Literature DB >> 198356

A further study on the regulation of cyclic nucleotide phosphodiesterase activity in neuroblastoma cells: effect of growth.

P K Sinha, K N Prasad.   

Abstract

Adenosine 3',5'-cyclic monophosphate (cyclic AMP) phsophodiesterase activity in mouse neuroblastoma cells in culture markedly increased during exponential growth and reached a maximal level at confluency; whereas guanosine 3'5'-cyclic monophosphate (cyclic GMP) phosphodiesterase activity only slightly but significantly increased under a similar experimental condition. The increase in cyclic AMP phosphodiesterase activity was blocked by both cycloheximide and dactinomycin, whereas the increase in cyclic GMP phosphodiesterase was blocked by only cycloheximide. When the confluent cells were replated at low density, the cyclic nucleotide phosphodiesterase activity decreased; however, when they were plated at high cell density which equaled confluency, the enzyme activity did not decrease. Unlike cyclic AMP phosphodiesterase activity, cyclic GMP phosphodiesterase activity did not change significantly in prostaglandin E1-treated cells, but decreased in cells treated with the inhibitor of phosphodiesterase. Like cyclic AMP phosphodiesterase activity, cyclic GMP phosphodiesterase activity also did not change in cells treated with serum-free medium, X-irradiation, sodium butyrate and 6-thioguanine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198356     DOI: 10.1007/bf02615142

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  17 in total

1.  Cyclic nucleotide-dependent protein kinase activity in malignant and cyclic AMP-induced "differentiated" neuroblastoma cells in culture.

Authors:  K N Prasad; D Fogleman; M Gaschler; P K Sinha; J L Brown
Journal:  Biochem Biophys Res Commun       Date:  1976-02-23       Impact factor: 3.575

2.  Induction of ornithine decarboxylase in glioma and neuroblastoma cells.

Authors:  U Bachrach
Journal:  FEBS Lett       Date:  1976-09-15       Impact factor: 4.124

3.  Adenosine 3',5'-monophosphate in glial tumor cells. Alterations by 5-bromodeoxyuridine.

Authors:  J P Schwartz; N R Morris; B M Breckenridge
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

4.  Cyclic 3',5'-AMP phosphodiesterase activity during cyclic AMP-induced differentiation of neuroblastoma cells in culture.

Authors:  K N Prasad; S Kumar
Journal:  Proc Soc Exp Biol Med       Date:  1973-02

5.  Interaction with phosphodiesterase of free and kinase-complexed cyclic adenosine 3',5'-monophosphate.

Authors:  R F O'Dea; M K Haddox; N D Goldberg
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

6.  Basal level of neurotransmitter synthesizing enzymes and effect of cyclic AMP agents on the morphological differentiation of isolated neuroblastoma clones.

Authors:  K N Prasad; B Mandal; J C Waymire; G J Lees; A Vernadakis; N Weiner
Journal:  Nat New Biol       Date:  1973-01-24

7.  Regulation of phosphodiesterase synthesis: requirement for cyclic adenosine monophosphate-dependent protein kinase.

Authors:  H R Bourne; G M Tomkins; S Dion
Journal:  Science       Date:  1973-09-07       Impact factor: 47.728

8.  Cyclic AMP-mediated induction of the cyclic AMP phosphodiesterase of C-6 glioma cells.

Authors:  J P Schwartz; J V Passonneau
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  Prostaglandin E 1 effects on adenosine 3':5'-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts (mouse L cells-tissue culture-enzyme kinetics-prostaglandin homologues).

Authors:  V Maganiello; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Regulation of adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentrations of cyclic adenosine monophosphate (3T3-dibutyryl cyclic AMP-SV40-transformed cells-michaelis constants-L cells-prostaglandin E 1 ).

Authors:  M D'Armiento; G S Johnson; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.